Oxalic Acid for Interference Testing

CAT: 0952-C2010411Size: 500 mgDry Ice: NoHazardous: No
CAT#:0952-C2010411Size:500 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Oxalic Acid for Interference Testing_x000D_ Catalog number: C2010411_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 500 mg_x000D_ Molecular Weight or Concentration: 90.03 (g/mol)_x000D_ Supplied as: Powder_x000D_ Appearance: White solid_x000D_ Applications: waste product of metabolism that the body disposes of in the urine. Because of its poor solubility, oxalic acid often forms crystals in urine._x000D_ Storage: Room Temperature_x000D_ Keywords: Ethanedioic Acid, oxalate_x000D_ Grade: Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Goldstein BN, Wesler J, Nowacki AS, Reineks E, Natowicz MR. Investigations of_x000D_ blood ammonia analysis: Test matrices, storage, and stability. Clin Biochem._x000D_ 2017 Jun;50(9):537-539._x000D_ _x000D_ 2: Turkmen K, Erdur FM. The relationship between colonization of Oxalobacter_x000D_ formigenes serum oxalic acid and endothelial dysfunction in hemodialysis_x000D_ patients: from impaired colon to impaired endothelium. Med Hypotheses. 2015_x000D_ Mar;84(3):273-5._x000D_ _x000D_ 3: Pucci ND, Marchini GS, Mazzucchi E, Reis ST, Srougi M, Evazian D, Nahas WC._x000D_ Effect of phyllanthus niruri on metabolic parameters of patients with kidney_x000D_ stone: a perspective for disease prevention. Int Braz J Urol. 2018 Jul-_x000D_ Aug;44(4):758-764._x000D_ _x000D_ 4: Messa P, Londero D, Massarino F, Paganin L, Mioni G, Zattoni F, Cannella G._x000D_ Abnormal arachidonic acid content of red blood cell membranes and main_x000D_ lithogenic factors in stone formers. Nephrol Dial Transplant. 2000_x000D_ Sep;15(9):1388-93._x000D_ _x000D_ 5: Rodgers AL, Jappie-Mahomed D, van Jaarsveld PJ. Testing the dogma that total_x000D_ phospholipid fatty acid composition of blood plays a role in kidney stone_x000D_ pathogenesis, using a high-low risk human model: results from a pilot study._x000D_ Urolithiasis. 2019 Jun;47(3):255-261._x000D_ _x000D_ 6: Yildirim N, Cengiz M. Predictive clinical factors of chronic peripheral_x000D_ neuropathy induced by oxaliplatin. Support Care Cancer. 2020_x000D_ Oct;28(10):4781-4788._x000D_ 7: Zhang Z, Yu X, Geng X. Protective role of three differently processed corn_x000D_ bran on glucose and lipid concentrations in d-galactose-induced mice model. J_x000D_ Food Biochem. 2020 Aug;44(8):e13281. _x000D_ _x000D_ Products Related to Oxalic Acid for Interference Testing : Interference
Short Description
Catalog Number: C2010411 (500 mg)
Weight
0.8
Length
2
Width
0.9
Height
0.9

Popular Products